Further local deals are expected to take place in the course of the year LONDON, United Kingdom – ( BUSINESS WIRE ) – LivaNova PLC (NASDAQ: LIVN), a leader in medical technology and innovation, announced today that it has completed the initial completion of the divestment of its heart valve business (HV) to Gyrus Capital (Gyrus ) has successfully […]

LONDON–(BUSINESS WIRE)–LivaNova PLC (NASDAQ:LIVN), a market-leading medical technology and innovation company, and Gyrus Capital (Gyrus), an investment firm dedicated to investments in the healthcare and sustainability sectors, today announced they have entered into an agreement whereby entities funded and controlled by Gyrus will acquire the LivaNova heart valve (HV) business. The LivaNova Board of Directors […]